Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6851
VistaGen Therapeutics
VTGN
$11.2M
| $969K | ﹤0.01% |
321,885
-307,760
| -49% | -$1.05M |
|
6852
Graham Corp
GHM
$1.31B
| $969K | ﹤0.01% |
32,740
-15,205
| -32% | -$454K |
|
6853
SandRidge Energy
SD
$533M
| $969K | ﹤0.01% |
+79,210
| New | +$1.01M |
|
|
APLT
6854
CALL
DELISTED
Applied Therapeutics
APLT
| $968K | ﹤0.01% |
113,900
+22,300
| +24% | +$131K |
|
6855
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.84B
| $968K | ﹤0.01% |
+30,606
| New | +$945K |
|
6856
Invesco NASDAQ Internet ETF
PNQI
$535M
| $968K | ﹤0.01% |
22,280
+1,126
| +5% | +$46K |
|
|
INST
6857
CALL
DELISTED
Instructure Holdings, Inc.
INST
| $968K | ﹤0.01% |
41,100
+17,400
| +73% | +$411K |
|
6858
PUT
Mattel
MAT
$4.18B
| $968K | ﹤0.01% |
50,800
-23,700
| -32% | -$437K |
|
6859
Virtus Biotech Clinical Trials ETF
BBC
$50.7M
| $968K | ﹤0.01% |
34,631
-5,469
| -14% | -$151K |
|
6860
Nuveen Growth Opportunities ETF
NUGO
$2.49B
| $967K | ﹤0.01% |
29,832
+10,705
| +56% | +$338K |
|
6861
PUT
TPG
TPG
$8.32B
| $967K | ﹤0.01% |
16,800
-28,800
| -63% | -$1.42M |
|
6862
PUT
Grab
GRAB
$14.2B
| $967K | ﹤0.01% |
254,400
-227,700
| -47% | -$776K |
|
6863
CALL
Invesco Aerospace & Defense ETF
PPA
$8.68B
| $966K | ﹤0.01% |
8,400
-900
| -10% | -$97.8K |
|
6864
PUT
ADMA Biologics
ADMA
$2.12B
| $966K | ﹤0.01% |
48,300
+37,100
| +331% | +$577K |
|
6865
PUT
Frontdoor
FTDR
$5.79B
| $965K | ﹤0.01% |
20,100
-24,900
| -55% | -$1.08M |
|
6866
Camden National
CAC
$981M
| $964K | ﹤0.01% |
23,342
-15,594
| -40% | -$591K |
|
6867
CALL
Beazer Homes USA
BZH
$872M
| $964K | ﹤0.01% |
28,200
-8,000
| -22% | -$246K |
|
6868
Innovator Growth-100 Power Buffer ETF July
NJUL
$265M
| $963K | ﹤0.01% |
15,841
+8,718
| +122% | +$518K |
|
6869
ClearPoint Neuro
CLPT
$468M
| $963K | ﹤0.01% |
85,914
-99,078
| -54% | -$949K |
|
|
DAY
6870
PUT
DELISTED
Dayforce
DAY
| $962K | ﹤0.01% |
15,700
-6,100
| -28% | -$336K |
|
6871
CALL
Otter Tail
OTTR
$3.9B
| $961K | ﹤0.01% |
12,300
+4,200
| +52% | +$363K |
|
6872
CALL
Genco Shipping & Trading
GNK
$1.12B
| $961K | ﹤0.01% |
49,300
-35,600
| -42% | -$664K |
|
6873
PUT
iShares Preferred and Income Securities ETF
PFF
$13.1B
| $960K | ﹤0.01% |
28,900
+9,600
| +50% | +$309K |
|
6874
Alphatec Holdings
ATEC
$1.5B
| $959K | ﹤0.01% |
172,542
-58,480
| -25% | -$449K |
|
6875
CALL
Geron
GERN
$982M
| $958K | ﹤0.01% |
211,100
-17,600
| -8% | -$80K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.